BR100 Decreased By (-1.49%)
BR30 Decreased By (-1.14%)
KSE100 Decreased By (-0.85%)
KSE30 Decreased By (-1.61%)
AGHA 6.12 Decreased By ▼ -0.06 (-0.97%)
BECO 4.15 Decreased By ▼ -0.08 (-1.89%)
BML 60.90 Decreased By ▼ -0.94 (-1.52%)
BOP 30.91 Decreased By ▼ -0.79 (-2.49%)
CNERGY 12.11 Increased By ▲ 0.05 (0.41%)
CSIL 5.66 Increased By ▲ 0.03 (0.53%)
FCCL 58.21 Decreased By ▼ -0.50 (-0.85%)
FFL 13.40 Decreased By ▼ -0.07 (-0.52%)
FNEL 1.17 No Change ▼ 0.00 (0%)
KEL 6.10 Decreased By ▼ -0.04 (-0.65%)
KOSM 5.61 Decreased By ▼ -0.05 (-0.88%)
LOTCHEM 24.35 Decreased By ▼ -0.47 (-1.89%)
MLCF 100.19 Decreased By ▼ -1.90 (-1.86%)
NBP 175.81 Decreased By ▼ -3.85 (-2.14%)
NCPL 51.90 Increased By ▲ 1.85 (3.7%)
NPL 53.93 Increased By ▲ 1.03 (1.95%)
OGDC 313.80 Decreased By ▼ -2.44 (-0.77%)
PACE 9.24 Increased By ▲ 0.03 (0.33%)
PAEL 33.55 Decreased By ▼ -0.47 (-1.38%)
PIBTL 13.23 Decreased By ▼ -0.19 (-1.42%)
PPL 218.10 Decreased By ▼ -3.20 (-1.45%)
PRL 85.50 Increased By ▲ 0.90 (1.06%)
PTC 47.45 Decreased By ▼ -0.93 (-1.92%)
SSGC 22.65 Decreased By ▼ -0.29 (-1.26%)
TBL 9.20 Decreased By ▼ -0.10 (-1.08%)
TELE 7.17 Increased By ▲ 0.10 (1.41%)
TPL 25.50 Decreased By ▼ -0.36 (-1.39%)
TPLP 13.15 Increased By ▲ 0.04 (0.31%)
TREET 24.55 Decreased By ▼ -0.44 (-1.76%)
TRG 53.58 Decreased By ▼ -0.45 (-0.83%)
World

EU steps up fight against COVID variants pledging more funds

  • More contagious mutations are spreading fast across the world, and experts believe a British variant is likely to become prevalent on the European continent.
  • Brussels also pledged to accelerate regulatory approvals of upgraded vaccines that work against variants and to help ramp up vaccine production.
Published Updated
By

BRUSSELS: The European Commission on Wednesday pledged more funds to step up the EU's capabilities to identify and tackle variants of the new coronavirus.

More contagious mutations are spreading fast across the world, and experts believe a British variant is likely to become prevalent on the European continent.

However, most European Union states have so far done little or nothing to spot new variants, as they lack the capabilities to sequence the genome of the virus on a large scale.

The EU will invest at least 75 million euros ($90 million) to develop specialised tests to identify variants, and it will provide another 150 million euros to boost research in variants, the EU executive said in a statement.

Brussels also pledged to accelerate regulatory approvals of upgraded vaccines that work against variants and to help ramp up vaccine production.

It is also adding anti-variant clauses in its new supply deals to make sure companies develop shots that work against new variants, EU sources said.

Comments

Comments are closed for this article.